Vishnu Chemicals Limited — Updates, 24-01-2025: Press Release

Vishnu Chemicals Limited reported its highest-ever quarterly revenues for Q3FY25, reaching ₹371.2 Cr, which is a 22% increase year-over-year. Consolidated EBITDA surged by 55% to ₹63.5 Cr, while consolidated PAT rose significantly by 66% to ₹34.4 Cr compared to the same quarter last year. The domestic market demonstrated robust performance, with domestic sales contributing 61% of the revenue mix, up from 57% in the previous quarter. Notably, improvements in the profitability of Chromium and Barium chemicals were observed due to enhanced processes and better utilization levels. Freight costs also decreased to 16.9% of consolidated export sales. The company completed its acquisition of Jayansree Pharma Pvt Ltd in November 2024 and is progressing with statutory approvals for expansion in South Africa. Investors should monitor these developments, indicating a positive outlook for the company’s growth trajectory.